PharmAkea
focuses on the development of biopharmaceutical products... Read morePharmAkea
focuses on the development of biopharmaceutical products... Read more
News
Jan 07, 2020
Xconomy
PharmAkea: Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto
Aug 21, 2017
BioSpace
PharmAkea: PharmAkea Announces Successful Completion Of A Phase I Trial In Healthy Subjects For Its Novel LOXL2 Inhibitor, PAT-1251
Nov 21, 2016
PharmaLeaders
PharmAkea: PharmAkea, Celgene expand fibrotic disease therapy partnership
Nov 19, 2016
San Diego Business Journal
PharmAkea: PharmAkea, Celgene Extend Their Collaboration
PharmAkea Competitors
1
2
3
4
5
6
7
8
9
10